PHARMACEUTICAL AND BIOPHARMACEUTICAL (EIN 471015065) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2014

Legal Domicile

Principal Officer

GIL ROTH

Phone

2017887994

Tax Period

2023-01-01 to 2023-12-31

PHARMACEUTICAL AND BIOPHARMACEUTICAL, founded in 2014, is a small nonprofit in the Community Improvement sector that reported $588K in total revenue in fiscal year 2023. Revenue decreased 11% compared to the prior year.

Mission

REPRESENT THE INTERESTS OF THE PHARMACEUTICAL AND BIOPHARMACEUTICAL CONTRACT MANUFACTURING INDUSTRY

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $563,000

Program Service Revenue $17,759

Investment Income $6,927

Other Revenue $0

TOTAL REVENUE $587,686

Expense Breakdown

Grants Paid $0

Salaries & Benefits $220,030

Fundraising Expenses $0

Other Expenses $365,269

TOTAL EXPENSES $585,299

Year-over-Year Comparison

	2023	2022	Change
Revenue	$587,686	$656,885	-0.1%
Expenses	$585,299	$509,407	+0.1%
Net Income	$2,387	$147,478	-1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$207,128

Total Directors

$207,128

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
GIL ROTH	PRESIDENT	40.00	Officer Director	$178,628	$28,500	$207,128
TOM THORPE	TRUSTEE	1.00	Officer Director	$0	$0	$0
WILLIAM DONOVAN	TRUSTEE/SECRETARY	2.00	Director	$0	$0	$0
PETER BIGELOW	TRUSTEE/CHAIRMAN	2.00	Officer Director	$0	$0	$0
CORNELL STAMORAN	TRUSTEE/TREASURER	2.00	Officer Director	$0	$0	$0
STUART NEEDLEMAN	TRUSTEE	1.00	Director	$0	$0	$0
JESSICA SETTIMI	TRUSTEE	1.00	Director	$0	$0	$0
CHRISTOPHER PIERCE	TRUSTEE	1.00	Director	$0	$0	$0
TIM TYSON	TRUSTEE	1.00	Director	$0	$0	$0
TEDD GREEN	TRUSTEE	1.00	Director	$0	$0	$0
LEONARD M LEVIE	TRUSTEE	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$587,686	$585,299	$642,512	$2,387
2022	$656,885	$509,407	$642,531	$147,478
2021	$493,648	$479,969	$405,688	$13,679
2020	$496,643	$449,069	$393,138	$47,574
2019	$495,102	$473,019	$340,445	$22,083
2018	$437,993	$486,055	$318,362	$-48,062

PHARMACEUTICAL AND BIOPHARMACEUTICAL